Phase II Trial of Lenalidomide - Rituximab ± Dexamethasone in Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab

被引：0
作者：
Ahmadi, Tahamtan
Chong, Elise A. [1 ]
Gordon, Amanda [1 ]
Aqui, Nicole A. [2 ]
Xu, YinYan [2 ]
Svoboda, Jakub [1 ]
Nasta, Sunita D. [1 ]
Schuster, Stephen J. [1 ]
机构：
[1] Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：122 / 123
页数：2
相关论文
共 50 条
  • [1] Phase II Trial of Lenalidomide - Dexamethasone - Rituximab In Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab
    Ahmadi, Tahamtan
    Chong, Elise A.
    Gordon, Amanda
    Leinbach, Leah
    Aqui, Nicole A.
    Nasta, Sunita D.
    Svoboda, Jakub
    Goldstein, Steven C.
    Schuster, Stephen J.
    BLOOD, 2010, 116 (21) : 1616 - 1616
  • [2] Phase II Trial of Lenalidomide - Dexamethasone - Rituximab in Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab.
    Ahmadi, Tahamtan
    Chong, Elise A.
    Gordon, Amanda
    Aqui, Nicole A.
    Downs, Lisa H.
    Leinbach, Leah
    Goldstein, Steven C.
    Nasta, Sunita D.
    Janofsky, Stephen
    Maniar, Tapan N.
    Svoboda, Jakub
    Schuster, Stephen J.
    BLOOD, 2009, 114 (22) : 677 - 677
  • [3] Combination of Lenalidomide and Rituximab Overcomes Rituximab Resistance in Patients with Indolent B-cell and Mantle Cell Lymphomas
    Chong, Elise A.
    Ahmadi, Tahamtan
    Aqui, Nicole A.
    Svoboda, Jakub
    Nasta, Sunita D.
    Mato, Anthony R.
    Walsh, Kristy M.
    Schuster, Stephen J.
    CLINICAL CANCER RESEARCH, 2015, 21 (08) : 1835 - 1842
  • [4] Clinical experience with lenalidomide alone or in combination with rituximab in indolent B-cell and mantle cell lymphomas
    Ruan, J.
    Shah, B.
    Martin, P.
    Schuster, S. J.
    ANNALS OF ONCOLOGY, 2016, 27 (07) : 1226 - 1234
  • [5] Long-Term Outcomes of Lenalidomide and Rituximab in Rituximab-Resistant Patients with Indolent B Cell and Mantle Cell Lymphomas
    Chong, Elise A.
    Napier, Ellen
    Svoboda, Jakub
    Nasta, Sunita Dwivedy
    Mato, Anthony R.
    Landsburg, Daniel J.
    Schuster, Stephen J.
    BLOOD, 2017, 130
  • [6] Lenalidomide plus rituximab in patients with rituximab-resistant indolent B-cell and mantle cell lymphomas: 10-year follow-up.
    Gupta, Aditi
    Schuster, Stephen J.
    Svoboda, Jakub
    Nasta, Sunita
    Napier, Ellen
    Walsh, Kristy
    Chong, Elise A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Combined Lenalidomide, Low-Dose Dexamethasone, and Rituximab Achieves Durable Responses in Rituximab-Resistant Indolent and Mantle Cell Lymphomas
    Ahmadi, Tahamtan
    Chong, Elise A.
    Gordon, Amanda
    Aqui, Nicole A.
    Nasta, Sunita D.
    Svoboda, Jakub
    Mato, Anthony R.
    Schuster, Stephen J.
    CANCER, 2014, 120 (02) : 222 - 228
  • [8] Combined rituximab, bendamustine, and dexamethasone chemotherapy for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma: a multicenter phase II study
    Yosuke Matsumoto
    Tsutomu Kobayashi
    Yuji Shimura
    Eri Kawata
    Hisao Nagoshi
    Muneo Ohshiro
    Mio Sugitani
    Kazuho Shimura
    Toshiki Iwai
    Shin-ichi Fuchida
    Mihoko Yoshida
    Miki Kiyota
    Shinsuke Mizutani
    Yoshiaki Chinen
    Tomoko Takimoto-Shimomura
    Mitsushige Nakao
    Hiroto Kaneko
    Hitoji Uchiyama
    Nobuhiko Uoshima
    Hikari Nishigaki
    Yutaka Kobayashi
    Shigeo Horiike
    Chihiro Shimazaki
    Masafumi Taniwaki
    Junya Kuroda
    International Journal of Hematology, 2019, 110 : 77 - 85
  • [9] Combined rituximab, bendamustine, and dexamethasone chemotherapy for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma: a multicenter phase II study
    Matsumoto, Yosuke
    Kobayashi, Tsutomu
    Shimura, Yuji
    Kawata, Eri
    Nagoshi, Hisao
    Ohshiro, Muneo
    Sugitani, Mio
    Shimura, Kazuho
    Iwai, Toshiki
    Fuchida, Shin-ichi
    Yoshida, Mihoko
    Kiyota, Miki
    Mizutani, Shinsuke
    Chinen, Yoshiaki
    Takimoto-Shimomura, Tomoko
    Nakao, Mitsushige
    Kaneko, Hiroto
    Uchiyama, Hitoji
    Uoshima, Nobuhiko
    Nishigaki, Hikari
    Kobayashi, Yutaka
    Horiike, Shigeo
    Shimazaki, Chihiro
    Taniwaki, Masafumi
    Kuroda, Junya
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (01) : 77 - 85
  • [10] A Phase I/II Study of Lenalidomide in Combination with Rituximab in Relapsed/Refractory Mantle Cell Lymphoma
    Wang, Luhua
    Fayad, Luis
    Hagemeister, Fredrick B.
    Neelapu, Sattva
    Samaniego, Felipe
    McLaughlin, Peter
    Samuels, Barry
    Yi, Qing
    Pro, Barbara
    Fanale, Michelle
    Shah, Jatin
    Younes, Anas
    Bell, Neda
    Knight, Robert
    Zeldis, Jerome B.
    Cabanillas, Fernando
    Kwak, Larry
    Romaguera, Jorge
    BLOOD, 2009, 114 (22) : 1064 - 1065
12345